A new adult appendicitis score improves diagnostic accuracy of acute appendicitis--a prospective study.
Henna E Sammalkorpi, Panu Mentula, Ari Leppäniemi
https://pubmed.ncbi.nlm.nih.gov/24970111/Actively Recruiting
Led by Helsinki University Central Hospital · Updated on 2026-09-18
900
Participants Needed
3
Research Sites
104 weeks
Total Duration
This clinical trial investigates adult patients suspected of having appendicitis. It compares protocol-based selective imaging methods to routine imaging with ultrasound andor computed tomography CT. The study aims to determine if using clinical scoring to guide imaging or observation affects clinical outcomes, specifically the rates of negative appendectomies and complicated appendicitis. Participants are randomly assigned to one of three groups one group receives routine imaging starting with ultrasound and followed by CT if needed the second group receives selective imaging guided by the Adult Appendicitis Score AAS, with urgent surgery scheduled for high scores the third group undergoes selective observation based on the Appendicitis Severity Score ASS combined with selective imaging based on the AAS. Imaging and treatment decisions are made according to these scoring protocols. During the study, participants undergo abdominal imaging and clinical scoring assessments. Researchers monitor outcomes such as negative appendectomies and complicated appendicitis within 30 days after randomization. Secondary measures include confirmed appendicitis, CT scan use, adverse events up to one year, quality of life assessments, and costs during the first 30 days. The study follows participants for appendicitis outcomes up to two years.
CONDITIONS
Protocol Based Selective Imaging Versus Routine Computed Tomography or Ultrasound in Suspected Appendicitis
P
Panu Mentula, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Helsinki University Central Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Henna E Sammalkorpi, Panu Mentula, Ari Leppäniemi
https://pubmed.ncbi.nlm.nih.gov/24970111/J J Atema, C C van Rossem, M M Leeuwenburgh...
https://pubmed.ncbi.nlm.nih.gov/25963411/Kirsi S Lastunen, Ari K Leppäniemi, Panu J Mentula
https://pubmed.ncbi.nlm.nih.gov/35482016/Helsinki University Central Hospital
Lead Sponsor